BioInvent completes private placement

BioInvent International AB (SSE:BINV), Lund, Sweden Business: Cardiovascular, Cancer, Antibodies Date completed: 2/26/10 Type: Private placement Raised: SEK150 million ($20.8 million) Shares: 5.4 mill...